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Abstract 20 
Superantigens are ubiquitous within the Streptococcus pyogenes genome, which 21 
suggests that superantigen-mediated T-cell activation provides a significant selective 22 
advantage. S. pyogenes can carry a variable complement of the 11 known 23 
superantigens. We have identified two novel S. pyogenes superantigens, denoted speQ 24 
and speR, adjacent to each other in the core-chromosome of isolates belonging to eleven 25 
different emm-types. Although distinct from other superantigens, speQ and speR were 26 
most closely related to speK and speJ respectively. Recombinant SPEQ and SPER were 27 
mitogenic towards human peripheral blood mononuclear cells at ng/ml concentrations, 28 
and SPER was found to be more mitogenic than SPEQ.  29 
 30 
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Background 35 
The human pathogen, Streptococcus pyogenes, produces numerous virulence factors, 36 
including the extracellular superantigen toxins which are associated with the 37 
development of streptococcal toxic shock syndrome and scarlet fever.  Superantigens 38 
are able to cross-link the major histocompatibility complex (MHC) class II with the T 39 
cell receptor, bypassing the normal antigen presenting process and resulting in a high 40 
level of T cell activation, cytokine release and inflammation [1]. Although 41 
superantigens are thought to promote invasive disease, associated with high mortality 42 
rates, they may have a localized role in productive infection of the nasopharynx [2].  43 
Genetically and structurally related superantigens are also produced by Staphylococcus 44 
aureus and some other streptococcal species including the group C/G streptococci.  45 
There are 14 known streptococcal superantigens, 11 of which have been found in S. 46 
pyogenes; speA, speC, speG-speM, smeZ and ssa. All, except speJ and ssa, have been 47 
found in other streptococcal species as well. Three superantigen genes, szeN, szeP and 48 
szeF have been found only in S. equi subsp zooepidemicus [3].  Commons et al. later 49 
suggested renaming these to speN, speP and speO respectively to standardize the 50 
nomenclature across all streptococci [1].   51 
The superantigen genes speG, speJ and smeZ are encoded on the core chromosome but 52 
are not ubiquitous among S. pyogenes isolates. The other eight identified S. pyogenes 53 
superantigens are associated with prophages which have the potential to be mobile, 54 
introducing variability among isolates. As there is variability in the complement of 55 
superantigens carried by S. pyogenes isolates, along with mobility and sharing across 56 
other streptococcal species, there may be streptococcal superantigens that are yet to be 57 
identified. 58 
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Whilst testing for the presence of the 11 known superantigens in whole genome 59 
sequence (WGS) data from two S. pyogenes isolates from the pre-antibiotic era, we 60 
identified two new adjacent potential superantigen genes. We subsequently confirmed 61 
the presence of both genes in WGS from modern S. pyogenes isolates of different emm 62 
genotypes. The two new potential superantigen genes were not associated with 63 
recognised mobile genetic elements but were limited to certain emm-types. We have 64 
termed the genes speQ and speR, to follow the proposed nomenclature, and confirmed 65 
that they are indeed mitogenic towards human mononuclear cells.  66 
Methods 67 
Bacterial strains and growth conditions 68 
Two S. pyogenes emm60 isolates (H865 and H870) were first isolated in 1938 from 69 
puerperal sepsis patients at Queen Charlottes Hospital London. S. pyogenes isolates 70 
were cultured on Columbia blood agar plates or statically in Todd Hewitt broth at 37 71 
°C with 5% CO2. E. coli were cultured in LB at 37 °C with 225 rpm agitation and 72 
supplemented with 100ug/ml ampicillin where appropriate. 73 
Gene identification 74 
The speQ and speR genes were first identified from whole genome sequence (WGS) 75 
data of emm60 isolates H865 and H870 (short read archive ERR485817 and 76 
ERR485821, respectively). The presence and sequence of speQR were confirmed by 77 
PCR with primers spanning from the upstream ideS gene and the downstream 78 
hypothetical gene (speQR-region primers listed in Supplementary Table 1), and Sanger 79 
sequencing.   80 
Whole genome sequence analysis 81 
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Publicly available genome sequence fastq data for other S. pyogenes strains 82 
representing 86 different emm-types [4-6] were obtained and assembled de novo for 83 
identifying the presence or absence of speQ and speR.  84 
Fastq reads were assembled de novo using Velvet [7] or as previously described [6]. 85 
Assembly statistics are available at Mendeley Data (doi:10.17632/b89yzfcxp8.1 and 86 
doi:10.17632/f2d39nsfwk.1) or in the original study [6]. The genomic region 87 
spanning the potential speQR locus was extracted from de novo assemblies and 88 
examined for the presence or absence of complete superantigen genes, but in some 89 
cases the quality of assembled sequence data was too low for adequate confirmation 90 
of the complete speQR locus or the allelic sequence. 91 
Multi-locus sequence (MLST) data were obtained from de-novo assemblies of some 92 
UK data [8]. The presence of the 11 known streptococcal superantigens was determined 93 
by mapping of the short read sequence data to a pseudosequence of concatenated genes 94 
and confirmed through BLAST analysis of de-novo assemblies. Other MLST, emm-95 
genotype and superantigen data were obtained from the original studies. We excluded 96 
isolates where the emm type could not be definitively assigned. This included WGS 97 
from Kapatai et al. [5] where emm-type determined by WGS was reported to be 98 
different to the original Sanger sequenced emm-type, and emm-negative isolates from 99 
Chochua et al. [4].  100 
For phylogenetic analysis, fastq data was mapped to the completed S. pyogenes emm89 101 
reference genome H293 (HG316453.2) [9] and single nucleotide polymorphisms 102 
extracted from the core genome using SNP-sites [10] to generate a maximum likelihood 103 
phylogeny with RAxML [11].  104 
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Different speQR DNA sequence alleles were identified and submitted to Genbank 105 
(accession numbers: BK010649- BK010666, BK010692, BK010693).   106 
Recombinant protein expression 107 
BamHI-ended coding sequences for speQ.1 and speR.1 were amplified from H865 108 
gDNA using the primers listed in Supplementary Table 1 and cloned into the 109 
overexpression vector pET-19b (Novagen). Recombinant proteins were expressed in 110 
One Shot BL21(DE3) Chemically Competent E. coli (Life Technologies) and purified 111 
to apparent homogeneity using the Ni-NTA purification system (Novagen). Protein 112 
concentrations were measured using the Pierce Coomassie Plus (Bradford) Assay Kit. 113 
1 µg aliquots of each protein were separated by SDS-PAGE and visualized by 114 
InstantBlue staining (Expedeon). Recombinant IdeS was produced as previously 115 
described [12] and purified alongside recombinant SPEQ and SPER.  Recombinant 116 
SPEC was purchased from Toxin Technology, Inc (Sarasota, Florida). 117 
SPEQ and SPER antisera 118 
Antisera towards SPEQ and SPER were raised by immunizing mice intramuscularly 119 
ZLWKȝJRIUHFRPELQDQWSURWHLQHPXOVLILHGZLWK)UHXQG¶VFRPSOHWHDGMXYDQW120 
DQGERRVWHULPPXQL]DWLRQVDWDQGGD\VLQ)UHXQG¶VLQFRPSOHWHDGMXYDQW%ORRG121 
was collected on day 42 and the resulting antiserum was pooled. 122 
Human mononuclear cell proliferation assay.  123 
Healthy donor human mononuclear cells (MNCs) were purified as previously described 124 
[13] and diluted to 1x106 cells/ml in RPMI media (Life Technologies) (+10% FCS). 125 
Cells were seeded into 96 well plates at a concentration of 2x105/well and incubated 126 
with decreasing concentrations of recombinant protein for 48 h. Cell proliferation was 127 
measured with a Colorimetric Cell Proliferation BrdU ELISA (Roche).  128 
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Immunoblotting 129 
S. pyogenes culture supernatants collected at different time points were concentrated 130 
16-fold by TCA precipitation. Separated proteins were transferred to PVDF membrane 131 
(Hybond-LFP, GE Healthcare) which were blocked with 5% non-fat milk (Sigma 132 
Aldrich) in PBS and probed with a 1:1000 dilution of mouse antiserum raised against 133 
SPEQ or SPER. Bound antibodies were detected using a 1:80,000 dilution of HRP-134 
conjugated goat anti-mouse IgG (Abcam).  135 
RNA extraction and PCR 136 
RNA was extracted from early, mid and late logarithmic growth phases of the two 137 
emm60 strains (H865 and H870) using a hot acidic phenol method as previously 138 
described [14].  RNA samples were treated with Turbo DNA-free (Ambion) DNase and 139 
1 µg was converted into cDNA using Transcriptor reverse transcriptase (Roche) and 140 
random hexaoligos (RT+ samples). To control for contaminating genomic DNA 141 
equivalent reverse transcriptase negative (RT-) samples were generated with another 1 142 
µg but the Transcriptor reverse transcriptase was excluded from the reaction.  PCR for 143 
speQR co-transcription was performed on 200 ng of the RT+ cDNA and RT- samples 144 
using speQR primers (Supplementary Table 1) and visualized on an agarose gel.  145 
Ethics 146 
Normal human donor cells were acquired from an approved sub-collection of the 147 
Imperial College Tissue Bank. All murine procedures were approved by the local 148 
ethical review process at Imperial College London and conducted in accordance with 149 
the relevant, UK Home Office approved, project license. 150 
Results 151 
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Identification of two new potential superantigen genes; speQ and speR 152 
We sequenced the genomes of two viable emm60 isolates, originally collected in 1938 153 
from two puerperal sepsis patients, and analyzed the genomes for the presence of 154 
superantigens. We could not detect the presence of any of the known streptococcal 155 
superantigens by short read sequence mapping or BLAST analysis of de novo 156 
assembled genomes. The analysis did, however, indicate the presence of sequence in 157 
the genomes of both emm60 isolates with partial homology to speK. We identified this 158 
homologous sequence to be within one of two hypothetical genes located immediately 159 
downstream of the gene ideS (also known as mac) encoding for an immunoglobulin 160 
cleaving protease (Figure 1A). BLAST indicated that these genes were closely related 161 
to other streptococcal superantigens and carried the typical superantigen &WHUPLQDOȕ-162 
grasp domain [1].  We therefore predicted that these would be superantigen genes and 163 
denoted them speQ and speR. PCR and Sanger sequencing confirmed the WGS data. 164 
BLASTn and BLASTp of completed available S. pyogenes genomes also identified 165 
speQ and speR in an emm87 strain NGAS743 (DI45_05770 and DI45_05775 166 
respectively; Genbank CP007560.1) [16]. In isolates where full length speQ and speR 167 
genes were absent, a C-terminal fragment of speR was present immediately downstream 168 
of ideS (Figure 1A). We also performed BLASTp analysis of the entire NCBI database, 169 
excluding S. pyogenes, but did not identify SPEQ or SPER in any other available 170 
genomes including other streptococcal species.  171 
Phylogenetic analysis of the amino acid sequences of SPEQ, SPER, and all other 172 
available superantigen alleles from all streptococcal species [1] demonstrated that, 173 
although phylogenetically distinct, SPEQ is closely related to the prophage-associated 174 
SPEK sharing 84% amino acid identity, and SPER is most closely related to the 175 
chromosomal SPEJ sharing 64% amino acid identity (Figure 1B).  Comparisons were 176 
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made between SPEQ, SPEK, SPEJ and SPER to identify two superantigen signature 177 
amino acid motifs (Supplementary Figure 1) [1, 3]. SPER, like SPEJ, had the motif Y-178 
G-G-(LIV)-T-x4-N (Prosite PS00277) but only a partial match for this was identified in 179 
SPEQ and SPEK. All four superantigens had the motif K-x2-(LIVF)-x4-(LIVF)-D-x3-180 
R-x2-L-x5-(LIV)-Y (Prosite PS00278) and a C-terminal zinc binding domain (HxD).  181 
To determine the presence of speQR in other S. pyogenes genotypes, publicly available 182 
WGS fastq data were obtained from the short read archive for UK isolates [5, 6] and 183 
USA isolates [4] totaling 4,262 genomes tested covering 86 different genotypes 184 
(Supplementary Table 2). Complete speQ and speR were identified in the assembled 185 
genome sequence of isolates belonging to the emm-types emm9, 15, 18, 42, 53, 58, 60, 186 
77, 87, 94 and 169 (Supplementary Table 3). However, not all isolates belonging to 187 
some of these genotypes carried the complete speQR locus, which was unexpected 188 
given the lack of association with mobile genetic elements. Only one out of 41 emm18 189 
(USA isolate 20154046) had complete speQR, as did 21/24 emm58 isolates and 49/72 190 
emm77 isolates. The presence or absence of complete speQR in these genotypes 191 
appeared to be associated with divergent lineages and multi-locus sequence types 192 
(MLST) within these emm-types (Supplementary Figure 2, Supplementary Table 3), 193 
indicative of the same emm gene on completely different genetic backgrounds. In 194 
contrast, all emm94 isolates were MLST-89, but 2/50 did not carry the complete speQR 195 
allele and formed a separate sub-lineage. As these isolates were still relatively closely 196 
related there may have been a horizontal gene transfer event of the speQR region. 197 
The majority of isolate genomes that were positive for speQR were also positive for at 198 
least one other superantigen gene (Supplementary Table 3). The exceptions to this were 199 
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4/5 emm60, 1/72 emm77, and 2/2 emm169 isolates where no superantigen genes other 200 
than speQR were detected [4].  201 
From the WGS analysis, thirteen DNA alleles for speQ and seven DNA alleles for speR 202 
were identified. The variation was limited to single nucleotide polymorphisms, except 203 
a region in speQ which varied in the number of a 15bp/5aa repeat (Supplementary 204 
Figure 3).  This 15bp/5aa region repeated twice, four times and five times in three 205 
alleles, speQ.2, speQ.4 and speQ.5 respectively; these alleles were found only in 206 
genotype emm9 isolates. Based on amino acid sequence, SPEQ.1, SPEQ.6, SPEQ.8, 207 
SPEQ.11 and SPEQ.12 were identical. SPEQ.3, SPEQ.7, SPEQ.9 and SPEQ.13 each 208 
differ from SPEQ.1 by one amino acid residue and SPEQ.10 differs by two amino acid 209 
residues. For SPER, SPER.1, SPER.2, SPER.4, and SPER.5 were identical by amino 210 
acid sequence, but SPER.3, SPER.6 and SPER.7 each differ by one amino acid.  211 
Recombinant SPEQ and SPER induced proliferation of human mononuclear cells 212 
To determine if SPEQ and SPER were capable of inducing proliferation of human T 213 
cells, we recombinantly expressed both proteins in E. coli (Figure 2A). These 214 
recombinant toxins represented gene alleles speQ.1 and speR.1. Purified toxins were 215 
then used to stimulate human mononuclear cells (MNCs) and proliferation was 216 
measured by BrdU uptake (Figure 2B). Both SPEQ and SPER induced proliferation, 217 
although a 10-fold greater concentration of SPEQ than SPER was required to generate 218 
an equivalent response. Proliferation after stimulation with another streptococcal 219 
superantigen, SPEC, required 100-1000-fold lower concentration than SPEQ and 220 
SPER. As a control, the non-mitogenic IdeS was recombinantly expressed and purified 221 
in the same manner as SPEQ and SPER but failed to stimulate any proliferation, as 222 
expected.   223 
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Both speQ and speR are expressed by S. pyogenes during culture 224 
To confirm speQ and speR expression by S. pyogenes, transcription and protein 225 
expression were measured. RNA was extracted at early, mid and late-logarithmic 226 
phases of growth of two emm60 strains and converted to cDNA for PCR. Primers that 227 
spanned across both speQ and speR confirmed the two genes are co-transcribed (Figure 228 
2C). Although only semi-quantitative, transcription appeared greatest at early and mid-229 
logarithmic phases of growth.  230 
Culture supernatants from the same two strains of emm60 S. pyogenes were probed by 231 
Western blot for SPEQ and SPER using an antibody raised in mice against recombinant 232 
proteins. SPEQ could be detected at late-logarithmic phase and following overnight 233 
culture in both emm60 strains (Figure 2D). Using rSPEQ at known concentrations the 234 
estimated concentration of SPEQ was ~90-127 ng/ml in late-logarithmic phase culture 235 
and increased to ~155-163 ng/ml by overnight culture. We were, however, unable to 236 
detect SPER using the rSPER murine antibody in either strain at any growth phase, 237 
which was unexpected given the co-transcription.   238 
Discussion 239 
We identified two potential superantigen genes present in the chromosomes of two 240 
1930¶s S. pyogenes emm60 isolates and subsequently identified the same genes in 241 
isolates belonging to 10 other emm-types in modern international isolates. We termed 242 
these genes speQ and speR and confirmed that they were capable of inducing 243 
proliferation of human cells. 244 
We tested the genomes over 4000 different isolates representing 86 emm-types and 245 
detected speQR in strains belonging to emm9, 15, 18, 42, 53, 58, 60, 77, 87, 94 and 169, 246 
although both speQR positive and negative lineages existed within these genotypes 247 
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(Supplementary Figure 2). Both emm77 and emm87 have been reported as common 248 
causes of invasive disease in various countries [17].  249 
Like the majority of other superantigens, both speQ and speR carry two of the three 250 
classic superantigen motifs.  The third was absent in speQ, as also observed in the 251 
closest relative speK, although present in speR and may relate to the different mitogenic 252 
potential; 10-fold more SPEQ than SPER was required to generate an equivalent 253 
mitogenic response. The mitogenic activity of both SPEQ and SPER was 10-100 fold 254 
lower than that of SPEC. This may limit contribution of SPEQ/R to virulence in the 255 
presence of much more potent superantigens. The majority of isolates whose genomes 256 
tested positive for speQ/R also carried at least one other superantigen genes. 257 
Across the entire collection of 1441 USA isolates (previously all typed for the 11 known 258 
superantigen genes), the prevalence of speQR was 6%, similar to speL (5%) and speM 259 
(6%) [4].  The most commonly found superantigen gene within the USA collection was 260 
speG (93%) followed by smeZ (91%), speC (51%), speJ (41%), speA (26%), speH 261 
(25%), speI (23%), ssa (10%), speK (9%) [4]. Of those that were positive for speQR, 262 
the prevalence of smeZ was still high (94%) and similar for speK (11%) and speC 263 
(40%), but fewer were positive for speG (54%) as well as speA (4%), speH (4%), speI 264 
(1%), speJ (28%), and more were positive for ssa (41%), speL (16%) and speM (16%). 265 
This may, however, reflect an association of superantigen complement with emm-type. 266 
At least one superantigen gene was detected in all 1441 USA isolates, except for four 267 
(of 5) emm60 isolates and one (of 54) emm77 isolate [4]. We identified that these five 268 
µVXSHUDQWLJHQ QHJDWLYH¶ isolates were positive for speQR, consistent with our initial 269 
finding that two 1930s emm60 were only positive for speQR and no other known 270 
superantigens.  271 
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Interestingly, in all isolates where full length speQ and speR genes were absent, 272 
immediately downstream of ideS was a C-terminal fragment of speR (Figure 1A). This 273 
suggests that speQR genes were present in the most recent common ancestor of all emm-274 
types but were lost as the emm-types diverged. Despite being chromosomally encoded, 275 
speQ and speR were less frequent among contemporary sequenced isolates than the 276 
other chromosomally encoded superantigens speG, speJ and smeZ. Quite why speQ 277 
and speR have persisted in the emm types that we identified is unclear; this may reflect 278 
a requirement of S. pyogenes to express at least one superantigen.  279 
Although superantigens are implicated in the pathogenesis of scarlet fever and 280 
streptococcal toxic shock, it is widely recognized that the production of superantigens 281 
must play a role in S. pyogenes fitness [18, 19]. This has been borne out in 282 
epidemiological studies that show alterations of superantigen gene content to be 283 
implicated in emergence or expansion of new lineages in the population [20, 22, 23], 284 
and in animal models where superantigens are shown to be necessary for successful 285 
infection [2, 19]. 286 
Superantigens crosslink the major histocompatibility molecule (MHC) class II on 287 
antigen presenting cells with the T cell receptor. The binding of the T cell receptor 288 
RFFXUV WKURXJK WKH YDULDEOH 9 ȕ-UHJLRQ ZLWK D VSHFLILFLW\ WRZDUGV GLIIHUHQW 9ȕ289 
variants [18]. As eacKVXSHUDQWLJHQFDQDFWLYDWHDGLIIHUHQWUHSHUWRLUHRI9ȕWKHPRUH290 
superantigens expressed by S. pyogenes the greater the heterogeneity of T cell 291 
H[SDQVLRQ)XUWKHUZRUNLVUHTXLUHGWRGHWHUPLQHWKH9ȕSUHIHUHQFHRI63(4DQG63(5292 
but it may be that even in the presence of more potent superantigens, they still 293 
contribute to pathogenesis through the expansion of a different T cell repertoire.  294 
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Genetic comparison of speQ and speR with the other known streptococcal 295 
superantigens indicated that they were closely related to the prophage-associated speK 296 
and the core chromosomal speJ, respectively. As SPEQ shares 84% amino acid identity 297 
with SPEK, it is possible that speK originated from speQ that was picked up by a 298 
bacteriophage. We did not identify any speQR orthologues in the available genomes of 299 
other streptococcal species.  300 
Although we identified thirteen different alleles of speQ, the most common was speQ.1, 301 
found in 81% (174/216) of speQR-positive isolate genomes where we could confirm 302 
the allele. It was also the original allele we identified in the emm60 isolates from the 303 
1930s. The alleles speQ.2, speQ.4 and speQ.5 that vary by a repeat region were 304 
restricted to the emm9 genotype. It is unclear as to the significance of this or the impact 305 
the repeat region may have on mitogenic activity of these alleles. The original 1930s 306 
emm60 speR allele, speR.1 was found in 40% (82/216) but the most common was 307 
speR.2, found in 56% (120/216) of speQR-positive isolate genomes; these two alleles 308 
should, however, encode identical proteins.   309 
Co-transcription of speQR was detected with greater expression in the early stages of 310 
exponential growth. Surprisingly, we were unable to detect SPER protein in S. 311 
pyogenes culture supernatant, although we were able to detect SPEQ at levels similar 312 
to SPEC expressed by emm3 S. pyogenes [22]. Other superantigens have been shown 313 
to be sensitive to SPEB degradation [23], and this may be the case for SPER. It is also 314 
possible that the antibody we raised, while able to detect recombinant SPER, was 315 
unable to detect native SPER.  316 
We have shown that there are now 16 streptococcal superantigen genes; each one may 317 
play a role in promoting S. pyogenes virulence. While the benefits of superantigen 318 
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production remain incompletely understood, the ubiquitous presence of superantigen 319 
genes within the S. pyogenes genome suggests that they do play a significant role in S. 320 
pyogenes disease.  321 
 322 
Funding 323 
This work was supported by the NIHR Biomedical Research Centre awarded to 324 
Imperial College NHS Healthcare Trust (SS, MR), and Imperial College JRF (CET).  325 
 326 
Acknowledgements The authors acknowledge the NIHR Biomedical Research Centre 327 
Tissue Bank at Imperial College 328 
 329 
 330 
References 331 
1. Commons RJ, Smeesters PR, Proft T, Fraser JD, Robins-Browne R, Curtis N. 332 
Streptococcal superantigens: categorization and clinical associations. Trends 333 
Mol Med 2014; 20:48-62. 334 
2. Zeppa JJ, Kasper KJ, Mohorovic I, Mazzuca DM, Haeryfar SMM, McCormick JK. 335 
Nasopharyngeal infection by Streptococcus pyogenes requires superantigen-336 
responsive Vbeta-specific T cells. Proc Natl Acad Sci U S A 2017. 337 
3. Paillot R, Darby AC, Robinson C, et al. Identification of three novel superantigen-338 
encoding genes in Streptococcus equi subsp. zooepidemicus, szeF, szeN, and 339 
szeP. Infect Immun 2010; 78:4817-27. 340 
4. Chochua S, Metcalf BJ, Li Z, et al. Population and whole genome sequence based 341 
characterization of invasive group A streptococci recovered in the United States 342 
during 2015. MBio 2017; 8. 343 
16 
 
5. Kapatai G, Coelho J, Platt S, Chalker VJ. Whole genome sequencing of group A 344 
Streptococcus: development and evaluation of an automated pipeline for emm 345 
gene typing. PeerJ 2017; 5:e3226. 346 
6. Turner CE, Bedford L, Brown NM, et al. Community outbreaks of group A 347 
Streptococcus revealed by genome sequencing. Sci Rep 2017; 7:8554. 348 
7. Zerbino DR, Birney E. Velvet: algorithms for de novo short read assembly using de 349 
Bruijn graphs. Genome Res 2008; 18:821-9. 350 
8. Page AJT, B.; Keane, J.A. Multilocus sequence typing by blast from de novo 351 
assemblies against PubMLST. Journal of Open Source Software 2016; 1. 352 
9. Turner CE, Abbott J, Lamagni T, et al. Emergence of a New Highly Successful 353 
Acapsular Group A Streptococcus Clade of Genotype emm89 in the United 354 
Kingdom. MBio 2015; 6:e00622. 355 
10. Page AJ, Taylor B, Delaney AJ, et al. SNP-sites: rapid efficient extraction of SNPs 356 
from multi-FASTA alignments. Microb Genom 2016; 2:e000056. 357 
11. Stamatakis A. RAxML version 8: a tool for phylogenetic analysis and post-analysis 358 
of large phylogenies. Bioinformatics 2014; 30:1312-3. 359 
12. Reglinski M, Lynskey NN, Sriskandan S. Modification of the classical Lancefield 360 
assay of group A streptococcal killing to reduce inter-donor variation. J 361 
Microbiol Methods 2016; 124:69-71. 362 
13. Unnikrishnan M, Altmann DM, Proft T, et al. The bacterial superantigen 363 
streptococcal mitogenic exotoxin Z is the major immunoactive agent of 364 
Streptococcus pyogenes. J Immunol 2002; 169:2561-9. 365 
14. Turner CE, Kurupati P, Jones MD, Edwards RJ, Sriskandan S. Emerging role of the 366 
interleukin-8 cleaving enzyme SpyCEP in clinical Streptococcus pyogenes 367 
infection. J Infect Dis 2009; 200:555-63. 368 
17 
 
15. Petersen TN, Brunak S, von Heijne G, Nielsen H. SignalP 4.0: discriminating signal 369 
peptides from transmembrane regions. Nat Methods 2011; 8:785-6. 370 
16. Athey TB, Teatero S, Sieswerda LE, et al. High incidence of invasive group A 371 
Streptococcus disease caused by strains of uncommon emm types in Thunder 372 
Bay, Ontario, Canada. J Clin Microbiol 2016; 54:83-92. 373 
17. Gherardi G, Vitali LA, Creti R. Prevelent emm types among invasive GAS in 374 
Europe and North America since year 2000. Front Public Health 2018; 6:59. 375 
18.  Proft T, Fraser JD. Streptococcal Superantigens: Biological properties and potential 376 
role in disease. In: Ferretti JJ, Stevens DL, Fischetti VA, editors. Streptococcus 377 
pyogenes : Basic Biology to Clinical Manifestations [Internet]. Oklahoma City. 378 
2016. 379 
19. Kasper KJ, Zeppa JJ, Wakabayashi AT et al. Bacterial superantigens promote acute 380 
nasopharyngeal infection by Streptococcus pyogenes in a human MHC Class 381 
II-dependent manner. PLoS Pathog 2014; e1004155.   382 
20. Nasser W, Beres SB, Olsen RJ et al. Evolutionary pathway to increased virulence 383 
and epidemic group A Streptococcus disease derived from 3,615 genome 384 
sequences. PNAS 2014; 111:E1768-E1776.  385 
21. Al-Shahib A, Underwood A, Afshar B et al.  Emergence of a novel lineage 386 
containing a prophage in emm/M3 group A Streptococcus associated with 387 
upsurge in invasive disease in the UK. Microb Genom 2016; e000059.  388 
22. Afshar B, Turner CE, Lamagni TL, et al. Enhanced nasopharyngeal infection and 389 
shedding associated with an epidemic lineage of emm3 group A Streptococcus. 390 
Virulence 2017; 8:1390-400. 391 
18 
 
23. Kansal RG, Nizet V, Jeng A, Chuang WJ, Kotb M. Selective modulation of 392 
superantigen-induced responses by streptococcal cysteine protease. J Infect Dis 393 
2003; 187:398±407. 394 
  395 
19 
 
 396 
 397 
Figure 1. Schematic representation of the chromosomal location of speQ and speR 398 
and similarity to other superantigens. (A) In emm-types where the two superantigens 399 
genes speQ (blue) and speR (green) were present in the chromosome they were located 400 
immediately downstream of the gene ideS (orange) encoding for the immunoglobulin 401 
cleaving protease, and upstream of a gene encoding for a hypothetical protein (black).  402 
In emm-types where the full length superantigen genes were absent in the chromosome, 403 
a C-terminal ~364 base pair fragment of speR was present downstream of ideS. (B) 404 
Available sequences of the superantigen alleles determined by Commons et al [1] were 405 
20 
 
obtained and translated to amino acids.  The signal sequences were identified by 406 
SignalP [15] and excluded before alignment with the predicted mature protein 407 
sequences of SPEQ (blue) and SPER (green) alleles. Core chromosome (i.e. not 408 
associated with known prophage elements) S. pyogenes superantigens are shaded grey. 409 
The Staphylococcus aureus superantigen SEB sequence was also included and used to 410 
root the maximum likelihood tree.  The 28 SPEG alleles and 39 SMEZ alleles were 411 
condensed to a single branch for illustration purposes. Scale represents amino acid 412 
substitutions per site. Bootstrap values greater than 80% are shown.  413 
  414 
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 415 
 416 
Figure 2. Activity and expression of SPEQ/R. (A) Instant blue stained SDS-PAGE 417 
gel of purified recombinantly-expressed SPEQ and SPER which were then used to 418 
stimulate human mononuclear cells (MNCs). (B) Proliferation of MNCs, measured by 419 
BrdU assay, required 10 fold more SPEQ (solid line, squares) than SPER (dashed line, 420 
triangles).  The streptococcal superantigen SPEC (grey dashed line, circles) induced 421 
proliferation at a concentration ~100 fold lower than SPER.  The protein IdeS (dotted 422 
line, diamonds) which was expressed and purified in the same manner as SPEQ and 423 
SPER, induced no proliferation of MNCs at any concentration used. Data represent 424 
mean and SD from a single MNC donor representative of data from two other donors. 425 
(C) RNA was extracted from two strains of S. pyogenes emm60 cultured to early (E), 426 
mid (M) and late (L) logarithmic phase and converted to cDNA.  This was repeated on 427 
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two separate occasions (Exp1 and Exp2) and gave very similar results.  PCR was 428 
performed on 200ng of cDNA using primers that spanned speQ and speR and, for both 429 
strains and in both experiments, a band was detected at ~1kb following PCR on the 430 
RT+ samples, confirming co-transcription of speQ and speR.  No bands were present 431 
in samples where the reverse transcriptase had been excluded from the RNA to cDNA 432 
reverse transcription reaction (RT-), suggesting no contamination of genomic DNA.  433 
(D) SPEQ was detected by Western blot in the culture supernatant of two emm60 strains 434 
(Strain 1 and Strain 2) at late logarithmic phase (L) and following overnight culture 435 
(O), but not at early (E) and only faintly at mid (M) logarithmic phase. A standard curve 436 
of 100, 50, 25 and 12.5 ng of rSPEQ was included to provide quantification.  Culture 437 
supernatants were concentrated 20-fold. 438 
  439 
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Supplementary Figures 440 
 441 
  PS00277   PS00278     Zn 442 
SPEQ DGGIIKTSDV  NNMVTLQEIDVRLRKSLMGDSKIK  HFD 443 
SPEK DGGIIKTSDV  NNIVTLQEIDVRLRKSLMGDSKIK  HFD 444 
SPER YGGITPSTDD  KDIVTIQEFDFKIRKFLMESKEIY  HFD 445 
SPEJ YGGVTPSVNS  KPIFTIQEFDFKIRQYLMQTYKIY  HFD 446 
 YGG*TxxxxN  Kxx*xxxx*DxxxRxxLxxxxx*Y  HxD 447 
  (LIV)  (LIVF)(LIVF)        (LIV)    448 
 449 
 450 
Supplementary Figure 1. Identification of three signature domains found in 451 
superantigens. The amino acid sequences of SPEQ and SPER were compared to their 452 
closest relatives SPEK and SPEJ to identify three motifs typically found in 453 
superantigens. The domain PS00277 (Prosite) was found in SPER and SPEJ with only 454 
one mismatch to the consensus sequence Y-G-G-(LIV)-T-x4-N.  Only three bases of 455 
this consensus sequence matched in SPEQ and SPEK indicating that this domain is not 456 
present. The domain PS00278 was identified in all four superantigens with only two 457 
mismatches to the consensus sequence K-x2-(LIVF)-x4-(LIVF)-D-x3-R-x2-L-x5-(LIV)-458 
Y in SPEQ and SPEK and no mismatches in SPER and SPEJ. The zinc binding domain 459 
(Zn) was also present in all strains. Consensus matching residues are indicated in red. 460 
* represents one of the 3-4 possible amino acids indicated in brackets on the line 461 
directly below.  462 
  463 
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 464 
Supplementary Figure 2. Intra-emm type lineages within genotypes carrying 465 
speQR. Isolates belonging to one of the four genotypes, emm18 (red), 58 (blue), 77 466 
(green) and 94 (orange), could be negative (square) or positive (positive) for the 467 
complete speQR depending on the lineage. Fastq data for isolates was mapped to the 468 
completed emm89 genome H293 (Black square) and single nucleotide polymorphisms 469 
used to generate a maximum-likelihood tree. Scale bar represents substitutions per 470 
site. Unfilled symbols; could not confirm presence or absence of speQR from 471 
assemblies.  472 
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 474 
 475 
Supplementary Figure 3. Varying number of repeats within SPEQ. A block of 5 476 
amino acids (bold) varied in number between alleles of SPEQ up to 5 repeats in 477 
SPEQ.5. Other alleles of SPEQ (3, 6-13) had just one block of these 5 amino acids, 478 
like SPEQ.1, but differed by other single nucleotide polymorphisms in other sites 479 
across the gene. Region shown is between 30 and 56 amino acids of the predicted 480 
mature protein (without the signal sequence). *Represents SPEQ.1, 3 and 6-13.  481 
 482 
  483 
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Supplementary Tables 484 
Supplementary Table 1: Primers used in this study 485 
Primer 6HTXHQFH¶-¶a Use 
speQR-
regionF 
AAGATAGTTGGAATCAGACC  
 
speQR 
confirmation 
and sequencing 
speQR-
regionR 
 
CTGAGCAGTTTTAGATTTGG speQR 
confirmation 
and sequencing 
SPEQ-F CCGGATCCAATGTGCTCATCAATTATTTTATATACTACTAAGG Recombinant 
SPEQ 
expression 
SPEQ-R CCGGATCCACTAGGCCAATATTTTATTTATTCATAAAGTATATC Recombinant 
SPEQ 
expression 
SPER-F CCGGATCCGATGTTTATTTATACATTTAAAACAG Recombinant 
SPER 
expression 
SPER-R CCGGATCCCGTCAATTGATCATATTTATCCAAAGC Recombinant 
SPER 
expression 
speQR-F ACCGATAAATGCCAAACAGG speQ/R co-
transcription 
speQR-R CTGTTGAAGGTGTGATTCCAC speQ/R co-
transcription 
speQR-
regionF 
AAGATAGTTGGAATCAGACC  
 
speQR 
confirmation 
and sequencing 
speQR-
regionR 
CTGAGCAGTTTTAGATTTGG speQR 
confirmation 
and sequencing 
aBamHI restriction sites are underlined 486 
 487 
 488 
  489 
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Supplementary Table 2. Details of genome sequence data obtained, assembled 490 
and tested for speQR. 491 
  Number assembled    
emm-type UK USA Total Tested speQR* 
Confirmed 
positive for 
speQR 
1 623 316 939 815 0 
2 44 28 72 72 0 
3 524 39 563 554 0 
4 128 52 180 177 0 
5 62 2 64 60 0 
6 115 22 137 132 0 
8 1 3 4 4 0 
9 9 10 19 19 19 (100%) 
11 55 50 105 104 0 
12 343 134 477 469 0 
15 0 1 1 1 0 
18 40 2 42 41 1 (2%) 
19 1 0 1 1 0 
22 19 5 24 24 0 
23 1 0 1 1 0 
24 0 1 1 1 0 
25 1 2 3 3 0 
27 1 2 3 3 0 
28 225 95 320 320 0 
29 0 1 1 1 0 
32 2 0 2 2 0 
33 2 1 3 3 0 
41 0 3 3 3 0 
42 0 1 1 1 1 (100%) 
43 2 0 2 2 0 
44 34 4 38 38 0 
49 7 20 27 27 0 
53 1 0 1 1 1 (100%) 
54 0 1 1 1 0 
57 1 0 1 1 0 
58 19 6 25 24 21 (88%) 
59 0 53 53 53 0 
60 0 5 5 5 5 (100%) 
63 1 6 7 5 0 
66 1 0 1 1 0 
68 5 5 10 10 0 
73 19 5 24 23 0 
74 2 0 2 2 0 
75 131 20 148 145 0 
76 16 18 34 34 0 
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77 18 54 72 72 49 (68%) 
78 1 0 1 1 0 
80 1 1 2 2 0 
81 26 26 52 52 0 
82 10 101 111 111 0 
83 0 14 14 14 0 
85 1 1 2 2 0 
86 1 0 1 1 0 
87 60 26 86 81 81 (100%) 
88 3 0 3 3 0 
89 312 185 497 490 0 
90 15 5 20 20 0 
91 0 3 3 3 0 
92 6 58 64 64 0 
93 1 0 1 1 0 
94 50 1 51 50 48 (96%) 
95 1 0 1 1 0 
99 1 0 1 1 0 
100 2 0 2 2 0 
101 0 5 5 5 0 
102 5 1 6 6 0 
103 4 1 5 5 0 
104 1 2 3 3 0 
106 1 2 3 3 0 
108 7 2 9 9 0 
109 1 0 1 1 0 
110 4 0 4 4 0 
111 0 1 1 1 0 
112 1 0 1 1 0 
113 2 1 3 3 0 
114 0 2 2 2 0 
118 1 25 26 26 0 
123 1 0 1 1 0 
134 1 0 1 1 0 
151 0 3 3 3 0 
165 1 1 2 2 0 
168 19 0 19 19 0 
169 2 0 2 2 2 (100%) 
171 1 0 1 1 0 
216 0 1 1 1 0 
217 1 0 1 1 0 
218 2 0 2 2 0 
227 0 1 1 1 0 
232 1 1 2 2 0 
234 0 1 1 1 0 
238 0 2 2 2 0 
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Total 3000 1440 4437 4262 228 
*low coverage or poor quality assembly data prevented confirmation of speQR 492 
presence or absence for some isolates 493 
  494 
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Supplementary Table 3: Isolates within genotypes positive for speQR     
 
        
 
        
Strain name Accession 
number 
emm-
type Reference speQR MLST speQ allele speR allele Other superantigen genes 
20155373 SRR5854238 9 [4] Yes 75 4 3 speG, ssa, smeZ 
20161091 SRR5853656 9 [4] Yes 75 4 3 speG, ssa, smeZ 
20161741 SRR5853688 9 [4] Yes 75 4 3 speG, ssa, smeZ 
20162662 SRR5853345 9 [4] Yes 75 4 3 speG, ssa, smeZ 
20163036 SRR5853687 9 [4] Yes 75 4 3 speG, ssa, smeZ 
GASEMM0302 ERR1732625 9 [5] Yes 75 4 3 speC, speG, ssa, smeZ 
GASEMM0360 ERR1734801 9 [5] Yes ± BLAST# 75     speG, ssa, smeZ 
GASEMM0925 ERR1733536 9 [5] Yes 75 4 3 speG, ssa, smeZ 
GASEMM1010 ERR1733752 9 [5] Yes 75 5 1 speG, ssa, smeZ 
GASEMM1070 ERR1734143 9 [5] Yes 75 2 1 speG, speL, speM, ssa, smeZ 
GASEMM1136 ERR1732759 9 [5] Yes - BLAST 75     speG, speL, speM, ssa, smeZ 
GASEMM1829 ERR1732548 9 [5] Yes 204 2 1 speG, speK, smeZ 
GASEMM2004 ERR1734206 9 [5] Yes  75 4 3 speC, speG, ssa, smeZ 
20155204 SRR5853974 9.2 [4] Yes 891 2 1 speG, smeZ 
20155603 SRR5854200 9.2 [4] Yes 891 2 1 speG, smeZ 
20156713 SRR5854163 9.2 [4] Yes 75 2 1 speC, speG, speL, speM, smeZ 
20160970 SRR5853365 9.2 [4] Yes 891 2 1 speG, speL, speM, smeZ 
20162407 SRR5853438 9.2 [4] Yes 891 2 1 speG, speL, speM, smeZ 
GASEMM1718 ERR1733280 9.2 [5] Yes 891 2 1 speG, smeZ 
20162136 SRR5853544 15.1 [4] Yes 872 1 5 speA, speC, speG, smeZ 
GASEMM0285 ERR1735410 18 [5] No 41* - - speA, speC, speG, speL, speM, smeZ 
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GASEMM0540 ERR1733461 18 [5] No 41* - - speA, speC, speG, speL, speM, smeZ 
GASEMM0561 ERR1734827 18 [5] No 41* - - speA, speC, speG, speL, speM, smeZ 
GASEMM0871 ERR1733017 18 [5] No 41* - - speA, speC, speG, speL, speM, smeZ 
GASEMM1160 ERR1735235 18 [5] No 41* - - speA, speC, speG, speL, speM, smeZ 
GASEMM1247 ERR1733168 18 [5] No 41* - - speA, speC, speG, speL, speM, smeZ 
GASEMM1418 ERR1734972 18 [5] No 41* - - speA, speC, speG, speL, speM, smeZ 
GASEMM1598 ERR1732549 18 [5] No 41* - - speA, speC, speG, speL, speM, smeZ 
GASEMM1656 ERR1735241 18 [5] No 41* - - speA, speC, speG, speL, speM, smeZ 
GASEMM1720 ERR1732620 18 [5] No 41* - - speA, speC, speG, speL, speM, smeZ 
GASEMM1766 ERR1734945 18 [5] No 41* - - speA, speC, speG, speL, speM, smeZ 
GASEMM1906 ERR1734065 18 [5] No 41* - - speA, speC, speG, speL, speM, smeZ 
GASEMM1910 ERR1734348 18 [5] No 41* - - speC, speG, speL, speM, smeZ 
GASEMM1967 ERR1734605 18 [5] No 41* - - speA, speC, speG, speL, speM, smeZ 
GASEMM2059 ERR1733917 18 [5] No 41* - - speC, speG, speL, speM, smeZ 
GASEMM2067 ERR1732772 18 [5] No 41* - - speA, speC, speG, speL, speM, smeZ 
GASEMM2130 ERR1733147 18 [5] No 41* - - speA, speC, speG, speL, speM, smeZ 
GASEMM2190 ERR1735052 18 [5] No 41* - - speA, speC, speG, speL, speM, smeZ 
GASEMM2229 ERR1733524 18 [5] No 41* - - speA, speC, speG, speL, speM, smeZ 
GASEMM2230 ERR1733448 18 [5] No 41* - - speA, speC, speG, speL, speM, smeZ 
GASEMM2651 ERR1734606 18 [5] No 41* - - speA, speC, speG, speL, speM, smeZ 
GASEMM2655 ERR1732562 18 [5] No 41* - - speA, speC, speG, speL, speM, smeZ 
GASEMM2713 ERR1732983 18 [5] No 41* - - speA, speC, speG, speL, speM, smeZ 
GASEMM2729 ERR1734538 18 [5] No 41* - - speA, speC, speG, speL, speM, smeZ 
GASEMM2867 ERR1734893 18 [5] No 41* - - speA, speC, speG, speL, speM, smeZ 
GASEMM2895 ERR1733782 18 [5] No 41* - - speA, speC, speG, speL, speM, smeZ 
GASEMM3031 ERR1734236 18 [5] No 41* - - speC, speG, speL, speM, smeZ 
20154046 SRR5858678 18.12 [4] Yes 535 1 5 speA, speG, speK, smeZ 
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GASEMM1747 ERR1735058 18.21 [5] No 402 - - speA, speG, smeZ 
GASEMM1752 ERR1733080 18.21 [5] No 402 - - speA, speG, smeZ 
GASEMM0528 ERR1733900 18.29 [5] No 42 - - speA, speC, speG, speL, speM, smeZ 
GASEMM0573 ERR1732511 18.29 [5] No 42 - - speA, speC, speG, speL, speM, smeZ 
GASEMM0802 ERR1734573 18.29 [5] No 42 - - speA, speC, speG, speL, speM, smeZ 
GASEMM1288 ERR1734851 18.29 [5] No 42 - - speA, speC, speG, speL, speM, smeZ 
GASEMM2071 ERR1733665 18.29 [5] No 42 - - speA, speC, speG, speL, speM, smeZ 
GASEMM2122 ERR1734499 18.29 [5] No 41* - - speC, speG, speL, speM, smeZ 
GASEMM2087 ERR1732492 18.38 [5] No 42 - - speA, speC, speG, speL, speM, smeZ 
GASEMM2351 ERR1733901 18.39 [5] No 41* - - speA, speC, speG, speL, speM, smeZ 
GASEMM2453 ERR1732505 18.39 [5] No 41* - - speA, speC, speG, speL, speM, smeZ 
GASEMM2693 ERR1734737 18.39 [5] No 41* - - speA, speC, speG, speL, speM, smeZ 
GASEMM2376 ERR1732816 18.4 [5] No 41* - - speA, speC, speG, speL, speM, smeZ 
20156711 SRR5854193 18.7 [4] No 42* - - speC, speG, speL, speM, ssa, smeZ 
20161097 SRR5853770 42 [4] Yes 80 6 1 speG, speH, speI, smeZ 
GASEMM0926 ERR1733963 53 [5] Yes 363 13 7 speG, speH, speI, speM, smeZ 
20152179 SRR5858386 58 [4] Yes 176 1 1 speG, ssa, smeZ 
20155380 SRR5853860 58 [4] Yes 176 1 1 speG, ssa, smeZ 
20156103 SRR5853785 58 [4] Yes 176 1 1 speG, ssa, smeZ 
20156726 SRR5854259 58 [4] Yes 176 1 1 speG, ssa, smeZ 
GASAR0061 ERS361761 58 [6] Yes 176 3 1 speG, speH, speI, ssa, smeZ 
GASEMM0384 ERR1733815 58 [5] Yes 176 3 1 speG, ssa, smeZ 
GASEMM0530 ERR1735030 58 [5] Yes 176 3 1 speG, ssa, smeZ 
GASEMM0679 ERR1735323 58 [5] Yes 176 3 1 speG, ssa, smeZ 
GASEMM0880 ERR1734067 58 [5] Yes 176 3 1 speG, ssa, smeZ 
GASEMM0900 ERR1735007 58 [5] Yes 176 3 1 speG, ssa, smeZ 
GASEMM1156 ERR1732612 58 [5] Yes- BLAST 176   speG, ssa, smeZ 
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GASEMM1511 ERR1732902 58 [5] Yes 176* 3 1 speG, smeZ 
GASEMM1624 ERR1733931 58 [5] Yes 176 7 1 speG, ssa, smeZ 
GASEMM1915 ERR1733025 58 [5] Yes 176 3 1 speG, speH, smeZ 
GASEMM1985 ERR1733185 58 [5] Yes- BLAST 176*   speG, ssa, smeZ 
GASEMM2416 ERR1732690 58 [5] Yes 176 3 1 speG, ssa, smeZ 
GASEMM2441 ERR1734784 58 [5] Yes 176 3 1 speG, ssa, smeZ 
GASEMM3021 ERR1733289 58 [5] Yes 176 3 1 speC, speG, speH, smeZ 
20154011 SRR5858614 58.2 [4] Yes 176 1 1 speC, speG, speH, smeZ 
20156359 SRR5854013 58.2 [4] Yes 176 10 1 speC, speG, speH, smeZ 
GASEMM1431 ERR1734695 58.7 [5] Yes 176 3 1 speC, speG, smeZ 
GASEMM1086 ERR1735087 58.8 [5] No 985 - - speC, speG, smeZ 
GASEMM1108 ERR1735468 58.8 [5] No 985 - - speC, speG, smeZ 
GASEMM1933 ERR1734866 58.8 [5] No 549 - - speG, speK, smeZ 
20154028 SRR5858394 60.2 [4] Yes 53 1 1 None 
20161832 SRR5853686 60.2 [4] Yes 53 1 1 speG, smeZ 
20162105 SRR5853728 60.2 [4] Yes 53 1 1 None 
20162139 SRR5853537 60.2 [4] Yes 53 1 1 None 
20162155 SRR5853329 60.2 [4] Yes 53 1 1 None 
20152512 SRR5858716 77 [4] Yes 63 8 1 speA, smeZ 
20153541 SRR5858459 77 [4] No 399 - - speG, smeZ 
20153553 SRR5858462 77 [4] No 399 - - speG, smeZ 
20154045 SRR5858677 77 [4] Yes 63 1 1 speL, speM, smeZ 
20154151 SRR5858630 77 [4] Yes 63 1 1 smeZ 
20154558 SRR5858309 77 [4] Yes 63 1 1 speK, smeZ 
20154612 SRR5858670 77 [4] No 399 - - speG, smeZ 
20154792 SRR5858505 77 [4] Yes 63 1 1 None 
20155018 SRR5858422 77 [4] Yes 63 1 1 speC, smeZ 
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20155030 SRR5858695 77 [4] Yes 63 1 1 speC, smeZ 
20155035 SRR5858539 77 [4] Yes 63 1 1 smeZ 
20155065 SRR5853826 77 [4] Yes 63 1 1 speC, smeZ 
20155357 SRR5854098 77 [4] Yes 63 1 1 smeZ 
20155578 SRR5853970 77 [4] Yes 63 1 1 speL, speM, smeZ 
20155640 SRR5854282 77 [4] Yes 63 1 1 speC, smeZ 
20155641 SRR5854281 77 [4] Yes 63 1 1 speC, smeZ 
20155652 SRR5854144 77 [4] Yes 63 9 1 speL, speM, smeZ 
20156012 SRR5854073 77 [4] No 399 - - speG, smeZ 
20156017 SRR5853922 77 [4] Yes 63 1 1 speK, smeZ 
20156106 SRR5853788 77 [4] Yes 63 1 1 speK, smeZ 
20156164 SRR5854197 77 [4] Yes 63 1 1 smeZ 
20156171 SRR5854064 77 [4] Yes 63 1 1 smeZ 
20156324 SRR5854015 77 [4] No 399 - - speG, smeZ 
20156364 SRR5854021 77 [4] No 399 - - speC, speG, speH, speI, smeZ 
20156388 SRR5854152 77 [4] Yes 63 1 1 smeZ 
20156402 SRR5853904 77 [4] Yes 63 1 1 speK, smeZ 
20156442 SRR5853843 77 [4] No 399 - - speG, speK, speL, smeZ 
20156624 SRR5854091 77 [4] Yes 63 1 1 speK, smeZ 
20156633 SRR5853933 77 [4] No 399 - - speG, speH, speI, smeZ 
20156792 SRR5854166 77 [4] Yes 63 1 1 speL, speM, smeZ 
20160025 SRR5854032 77 [4] Yes 63 1 6 speK, smeZ 
20160171 SRR5853946 77 [4] Yes 63 1 1 speK, smeZ 
20160245 SRR5854087 77 [4] Yes 63 1 1 speC, smeZ 
20160322 SRR5853916 77 [4] Yes 63 1 1 speL, speM, smeZ 
20160750 SRR5853422 77 [4] Yes 63 1 1 speL, speM, smeZ 
20160953 SRR5853589 77 [4] No 904 - - speG, smeZ 
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20161075 SRR5853432 77 [4] No 399 - - speG, smeZ 
20161076 SRR5853433 77 [4] Yes 63 1 1 speC, smeZ 
20161082 SRR5853552 77 [4] Yes 63 1 1 speC, smeZ 
20161205 SRR5853474 77 [4] Yes 63 1 1 speL, speM, smeZ 
20161238 SRR5853603 77 [4] No 399 - - speG, smeZ 
20161721 SRR5853401 77 [4] Yes 63 1 1 speL, speM, smeZ 
20161722 SRR5853402 77 [4] No 399 - - speG, speJ, speL, speM, smeZ 
20161724 SRR5853404 77 [4] Yes 63 1 1 speL, speM, smeZ 
20161838 SRR5853507 77 [4] Yes 63 1 1 speL, speM, smeZ 
20162121 SRR5853652 77 [4] Yes 63 1 1 speL, speM, smeZ 
20162428 SRR5853748 77 [4] Yes 63 1 1 speC, smeZ 
GASEMM0134 ERR1732814 77 [5] Yes 63 1 1 speC, smeZ 
GASEMM0135 ERR1733196 77 [5] Yes 63 1 1 speC, smeZ 
GASEMM0352 ERR1734572 77 [5] Yes 63 1 1 speC, smeZ 
GASEMM0846 ERR1734088 77 [5] No 399 - - speG, speL, speM, smeZ 
GASEMM1061 ERR1733365 77 [5] Yes 63 1 1 smeZ 
GASEMM1453 ERR1735072 77 [5] No 399 - - speC, speG, speL, speM, smeZ 
GASEMM1494 ERR1733572 77 [5] Yes 63 1 1 speC, smeZ 
GASEMM1700 ERR1734961 77 [5] Yes 63 1 1 smeZ 
GASEMM1729 ERR1734104 77 [5] No 399 - - speG, speL, speM, smeZ 
GASEMM1761 ERR1734232 77 [5] Yes 63 1 1 smeZ 
GASEMM1833 ERR1735076 77 [5] Yes 63 1 1 speC, smeZ 
GASEMM2373 ERR1734646 77 [5] Yes 63 1 1 speL, smeM, smeZ 
GASEMM2748 ERR1733450 77 [5] No 399 - - speG, speL, speM, smeZ 
GASEMM2849 ERR1735297 77 [5] Yes 63* 1 1 smeZ 
GASEMM2882 ERR1734850 77 [5] Yes 63 1 1 speL, speM, smeZ 
GASEMM2883 ERR1732745 77 [5] Yes 63 1 1 speL, speM, smeZ 
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GASEMM2955 ERR1734264 77 [5] Yes 63 1 1 speC, smeZ 
GASEMM3037 ERR1733626 77 [5] Yes 63 1 1 speC, smeZ 
20155579 SRR5853969 77.4 [4] No 133 - - speG, speM, smeZ 
20155580 SRR5853964 77.4 [4] No 133 - - speG, speM, smeZ 
20155585 SRR5853820 77.4 [4] No 133 - - speG, speM, smeZ 
20161863 SRR5853342 77.4 [4] No 133 - - speG, speM, smeZ 
20161864 SRR5853343 77.4 [4] No 133 - - speG, speM, smeZ 
20161872 SRR5853623 77.4 [4] No 133 - - speG, speM, smeZ 
20165973 SRR5853525 77.4 [4] No 133 - - speG, speM, smeZ 
20152749 SRR5858550 87 [4] Yes 62 1 2 speG, speJ, ssa, smeZ 
20153605 SRR5858351 87 [4] Yes 62 1 2 speG, speJ, ssa, smeZ 
20154292 SRR5858368 87 [4] Yes 62 12 2 speC, speG, speJ, ssa, smeZ 
20155202 SRR5853973 87 [4] Yes 62 1 2 speC, speG, ssa, smeZ 
20155269 SRR5853953 87 [4] Yes 62 12 2 speC, speG, speJ, ssa, smeZ 
20155393 SRR5854175 87 [4] Yes 62 1 2 speG, speJ, ssa, smeZ 
20155602 SRR5854241 87 [4] Yes 62 1 2 speC, speG, speJ, ssa, smeZ 
20155658 SRR5854063 87 [4] Yes 62 1 2 speC, speG, speJ, ssa, smeZ 
20156112 SRR5853794 87 [4] Yes 62 1 2 speC, speG, speJ, ssa, smeZ 
20156396 SRR5854160 87 [4] Yes 62 1 2 speC, speG, speJ, ssa, smeZ 
20156412 SRR5854044 87 [4] Yes 62 1 2 speG, speJ, ssa, smeZ 
20156782 SRR5854122 87 [4] Yes 62 1 2 speC, speG, speJ, ssa, smeZ 
20160141 SRR5853847 87 [4] Yes 62 12 2 speC, speG, speJ, ssa, smeZ 
20160495 SRR5853645 87 [4] Yes 62 1 2 speC, speG, speJ, ssa, smeZ 
20160499 SRR5853530 87 [4] Yes 62 12 2 speC, speG, speJ, ssa, smeZ 
20160747 SRR5853526 87 [4] Yes 62 1 2 speC, speG, speJ, ssa, smeZ 
20160975 SRR5853469 87 [4] Yes 62 1 2 speC, speG, speJ, ssa, smeZ 
20160986 SRR5853485 87 [4] Yes 62 1 2 speC, speG, speJ, speK, ssa, smeZ 
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20161088 SRR5853698 87 [4] Yes 62 1 2 speC, speG, speJ, ssa, smeZ 
20161436 SRR5853392 87 [4] Yes 62 1 2 speC, speG, speJ, ssa, smeZ 
20162409 SRR5853434 87 [4] Yes 62 1 2 speC, speG, speJ, ssa, smeZ 
20162410 SRR5853435 87 [4] Yes 890 1 2 speC, speG, speJ, ssa, smeZ 
20162420 SRR5853559 87 [4] Yes 62 1 2 speC, speG, speJ, ssa, smeZ 
20162426 SRR5853750 87 [4] Yes 62 1 2 speG, speJ, ssa, smeZ 
20162648 SRR5853630 87 [4] Yes 62 1 2 speC, speG, speJ, ssa, smeZ 
GASAR0007 ERS361812 87 [6] Yes 62 1 2 speC, speG, speJ, ssa, smeZ 
GASEMM0188 ERR1733872 87 [5] Yes 62 1 2 speC, speG, speJ, ssa, smeZ 
GASEMM0189 ERR1733138 87 [5] Yes 62 1 2 speC, speG, speJ, ssa, smeZ 
GASEMM0234 ERR1734059 87 [5] Yes 62 1 2 speC, speG, speJ, ssa, smeZ 
GASEMM0264 ERR1733408 87 [5] Yes 62 1 2 speG, speJ, ssa, smeZ 
GASEMM0375 ERR1733437 87 [5] Yes 62 1 2 speC, speG, speH, speI, speJ, ssa, smeZ 
GASEMM0391 ERR1733949 87 [5] Yes 62 
Cannot 
confirm 
allele 
Cannot 
confirm 
allele speG, speJ, ssa, smeZ 
GASEMM0406 ERR1733763 87 [5] Yes 62 1 2 speC, speG, speJ, ssa, smeZ 
GASEMM0416 ERR1733324 87 [5] Yes 62 1 2 speG, speJ, ssa, smeZ 
GASEMM0422 ERR1734129 87 [5] Yes 62 1 2 speC, speG, speJ, ssa, smeZ 
GASEMM0460 ERR1733077 87 [5] Yes 62 1 2 speC, speG, speJ, ssa, smeZ 
GASEMM0470 ERR1734760 87 [5] Yes 62 1 2 speC, speG, speJ, ssa, smeZ 
GASEMM0558 ERR1735476 87 [5] Yes 62 1 2 speG, speJ, ssa, smeZ 
GASEMM0563 ERR1734436 87 [5] Yes 62 1 2 speC, speG, ssa, smeZ 
GASEMM0639 ERR1734864 87 [5] Yes 62 
Cannot 
confirm 
allele 
Cannot 
confirm 
allele speC, speG, speJ, ssa, smeZ 
GASEMM0696 ERR1734006 87 [5] Yes 62 1 2 speC, speG, speJ, ssa, smeZ 
GASEMM0736 ERR1732833 87 [5] Yes 62 1 2 speG, speJ, ssa, smeZ 
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GASEMM0781 ERR1733581 87 [5] Yes 62 
Cannot 
confirm 
allele 
Cannot 
confirm 
allele speC, speG, speJ, ssa, smeZ 
GASEMM0796 ERR1735275 87 [5] Yes 62 1 2 speC, speG, speJ, ssa, smeZ 
GASEMM0799 ERR1732942 87 [5] Yes 62 
Cannot 
confirm 
allele 
Cannot 
confirm 
allele speC, speG, speJ, ssa, smeZ 
GASEMM0800 ERR1734904 87 [5] Yes 62 1 2 speC, speG, speJ, ssa, smeZ 
GASEMM0920 ERR1735085 87 [5] Yes 62 1 2 speC, speG, speJ, ssa, smeZ 
GASEMM0968 ERR1734309 87 [5] Yes 62 1 2 speC, speG, speJ, ssa smeZ 
GASEMM0972 ERR1732701 87 [5] Yes 62 1 2 speC, speG, speJ, ssa, smeZ 
GASEMM0978 ERR1733699 87 [5] Yes 62 1 2 speC, speG, speJ, ssa, smeZ 
GASEMM1074 ERR1734225 87 [5] Yes 62 1 2 speC, speG, speJ, speK, ssa, smeZ 
GASEMM1215 ERR1734719 87 [5] Yes 62 1 2 speC, speG, speJ, ssa, smeZ 
GASEMM1258 ERR1733634 87 [5] Yes 62 1 2 speC, speG, speJ, ssa, smeZ 
GASEMM1295 ERR1732685 87 [5] Yes 62 1 2 speC, speG, speJ, ssa, smeZ 
GASEMM1313 ERR1733067 87 [5] Yes 62 1 2 speC, speG, speJ, ssa, smeZ 
GASEMM1315 ERR1733719 87 [5] Yes 62 1 2 speG, speJ, ssa, smeZ 
GASEMM1349 ERR1735221 87 [5] Yes 62 1 2 speC, speG, speJ, ssa, smeZ 
GASEMM1365 ERR1732481 87 [5] Yes 62 1 2 speC, speG, speJ, ssa, smeZ 
GASEMM1466 ERR1732652 87 [5] Yes 62 1 2 speC, speG, speJ, ssa, smeZ 
GASEMM1493 ERR1733772 87 [5] Yes 62 1 2 speG, speJ, ssa, smeZ 
GASEMM1512 ERR1733251 87 [5] Yes 62 1 2 speC, speG, speJ, ssa, smeZ 
GASEMM1572 ERR1734273 87 [5] Yes 62 1 2 speC, speG, speJ, ssa, smeZ 
GASEMM1573 ERR1734975 87 [5] Yes 62 1 2 speC, speG, speJ, ssa, smeZ 
GASEMM1575 ERR1733810 87 [5] Yes 62 1 2 speC, speG, speJ, ssa, smeZ 
GASEMM1577 ERR1733532 87 [5] Yes 62 1 2 speC, speG, speJ, ssa, smeZ 
GASEMM1601 ERR1735368 87 [5] Yes 62 1 2 speC, speG, speJ, ssa, smeZ 
GASEMM1688 ERR1735057 87 [5] Yes 62 1 2 speC, speG, speJ, ssa, smeZ 
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GASEMM1705 ERR1735155 87 [5] Yes 62 1 2 speC, speG, ssa, smeZ 
GASEMM1813 ERR1735180 87 [5] Yes 62 1 2 speC, speG, speJ, ssa, smeZ 
GASEMM1959 ERR1733991 87 [5] Yes 62 1 2 speC, speG, speJ, ssa, smeZ 
GASEMM2010 ERR1732466 87 [5] Yes 62 1 2 speC, speG, speJ, speK, ssa, smeZ 
GASEMM2377 ERR1735186 87 [5] Yes 62 1 2 speC, speG, speJ, ssa, smeZ 
GASEMM2378 ERR1734363 87 [5] Yes 62 1 2 speC, speG, speJ, ssa, smeZ 
GASEMM2379 ERR1733864 87 [5] Yes 62 1 2 speC, speG, speJ, ssa, smeZ 
GASEMM2551 ERR1733014 87 [5] Yes 62 1 2 speC, speG, speJ, ssa, smeZ 
GASEMM2568 ERR1732810 87 [5] Yes 62 1 2 speC, speG, speJ, ssa, smeZ 
GASEMM2846 ERR1734886 87 [5] Yes 62 1 2 speC, speG, speJ, ssa, smeZ 
GASEMM2942 ERR1732604 87 [5] Yes 62 1 2 speC, speG, speJ, ssa, smeZ 
GASEMM3012 ERR1734744 87 [5] Yes 62 1 2 speC, speG, speJ, ssa, smeZ 
GASEMM2424 ERR1734959 87.1 [5] Yes 62 1 2 speC, speG, speJ, ssa, smeZ 
20162638 SRR5853498 87.3 [4] Yes 62 11 2 speC, speG, ssa, smeZ 
20152838 SRR5858329 94 [4] No 89 - - speG, speH, smeZ 
GASEMM0336 ERR1735266 94 [5] Yes 89 1 2 speG, speH, smeZ 
GASEMM0542 ERR1733387 94 [5] Yes 89 1 2 speG, speH, smeZ 
GASEMM0725 ERR1735331 94 [5] Yes 89 1 2 speG, speH, smeZ 
GASEMM0801 ERR1735414 94 [5] Yes 89 1 2 speG, speH, smeZ 
GASEMM0818 ERR1734261 94 [5] Yes 89 1 2 speG, speH, smeZ 
GASEMM1157 ERR1734377 94 [5] Yes 89 1 2 speG, speH, smeZ 
GASEMM1158 ERR1734859 94 [5] Yes 89 1 2 speG, speH, smeZ 
GASEMM1343 ERR1733447 94 [5] Yes 89 1 2 speG, speH, smeZ 
GASEMM1360 ERR1733284 94 [5] Yes 89 1 2 speG, speH, smeZ 
GASEMM1374 ERR1732869 94 [5] Yes 89 1 2 speG, speH, smeZ 
GASEMM1379 ERR1732790 94 [5] Yes 89 1 2 speG, speH, smeZ 
GASEMM1438 ERR1734494 94 [5] Yes 89 1 2 speG, speH, smeZ 
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GASEMM1522 ERR1734834 94 [5] Yes 89 1 2 speG, speH, speL, speM, smeZ 
GASEMM1553 ERR1733938 94 [5] No 89 - - speG, speH, smeZ 
GASEMM1608 ERR1734955 94 [5] Yes 89 1 2 speG, speH, smeZ 
GASEMM1612 ERR1735069 94 [5] Yes 89 1 2 speG, speH, smeZ 
GASEMM1643 ERR1735361 94 [5] Yes 89 1 2 speG, speH, smeZ 
GASEMM1692 ERR1735041 94 [5] Yes 89 1 2 speG, speH, smeZ 
GASEMM1711 ERR1734820 94 [5] Yes 89 1 2 speG, speH, smeZ 
GASEMM1727 ERR1734329 94 [5] Yes 89 1 2 speG, speH, smeZ 
GASEMM1789 ERR1734110 94 [5] Yes- BLAST 89   speG, speH, smeZ 
GASEMM1832 ERR1734589 94 [5] Yes 89 1 2 speG, speH, smeZ 
GASEMM1864 ERR1732589 94 [5] Yes 89 1 2 speG, speH, smeZ 
GASEMM1874 ERR1733144 94 [5] Yes 89 1 2 speG, speH, smeZ 
GASEMM1885 ERR1733359 94 [5] Yes 89 1 2 speG, speH, smeZ 
GASEMM1900 ERR1734193 94 [5] Yes 89 1 2 speG, speH, smeZ 
GASEMM1911 ERR1733866 94 [5] Yes 89 1 2 speG, speH, smeZ 
GASEMM1969 ERR1734399 94 [5] Yes 89 1 2 speC, speG, speH, smeZ 
GASEMM2062 ERR1733775 94 [5] Yes 89 1 2 speC, speG, speH, smeZ 
GASEMM2124 ERR1734669 94 [5] Yes 89 1 2 speG, speH, smeZ 
GASEMM2148 ERR1733192 94 [5] Yes- BLAST 89   speG, speH, smeZ 
GASEMM2192 ERR1732991 94 [5] Yes 89 1 2 speG, speH, smeZ 
GASEMM2195 ERR1734642 94 [5] Yes - BLAST 89   speG, speH, smeZ 
GASEMM2212 ERR1732773 94 [5] Yes 89 1 2 speG, speH, smeZ 
GASEMM2301 ERR1734922 94 [5] Yes 89 1 2 speG, speH, smeZ 
GASEMM2363 ERR1733377 94 [5] Yes 89 1 2 speG, speH, smeZ 
GASEMM2467 ERR1733475 94 [5] Yes - BLAST 89   speG, speH, smeZ 
GASEMM2535 ERR1733579 94 [5] Yes 89 1 2 speG, speH, smeZ 
GASEMM2725 ERR1733407 94 [5] Yes 89 1 2 speG, speH, smeZ 
41 
 
 495 
GASEMM2800 ERR1735255 94 [5] Yes 89 1 2 speG, speH, smeZ 
GASEMM2847 ERR1733164 94 [5] Yes 89 1 2 speG, speH, smeZ 
GASEMM2866 ERR1733363 94 [5] Yes 89 1 2 speG, speH, smeZ 
GASEMM2868 ERR1732521 94 [5] Yes 89 1 2 speG, speH, smeZ 
GASEMM2871 ERR1732873 94 [5] Yes - BLAST 89   speG, speH, smeZ 
GASEMM2890 ERR1733409 94 [5] Yes 89 1 2 speG, speH, smeZ 
GASEMM2936 ERR1734650 94 [5] Yes 89 1 2 speG, speH, smeZ 
GASEMM2937 ERR1735320 94 [5] Yes 89 1 2 speG, speH, smeZ 
GASEMM2964 ERR1732797 94 [5] Yes 89 1 2 speG, speH, smeZ 
GASEMM3042 ERR1734749 94 [5] Yes 89 1 2 speG, speH, smeZ 
GASEMM1880 ERR1733790 169.3 [5] Yes 53 6 4 None 
GASEMM2308 ERR1733632 169.3 [5] Yes 53 6 4 None 
# BLAST; presence of the gene could be confirmed by BLAST but not from the de novo assembly therefore an allele was not assigned.  
* MLST closest match  
       
